Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus
- Status
- COMPLETED
- Phase
- PHASE2
Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
- Status
- RECRUITING
- Phase
- N/A
Study of Iressa in Patients With Relapsed or Refractory Acute Myelogenous Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS
- Status
- COMPLETED
- Phase
- PHASE2
Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Tarceva and Capecitabine for Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Prostate Immobilization Device Used During Radiation Treatments to Decrease Rectal Bleeding
- Status
- COMPLETED
- Phase
- PHASE2
Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Title XELOX FOR SALIVARY GLAND CANCERS
- Status
- TERMINATED
- Phase
- PHASE2
Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2